Package Insert: Information for the Patient
dutasteride
Read this package insert carefully before starting to take this medication, as it contains important information for you.
Contents of the package and additional information
Avidart is used in men to treat an enlarged prostate(benign prostatic hyperplasia),a non-cancerous growth of the prostate caused by excessive production of a hormone called dihydrotestosterone.
The active ingredient is dutasteride. Avidart belongs to a group of medications called 5-alpha reductase inhibitors.
As the prostate grows in size, it may produce urinary problems such as difficulty in urinating and a need to urinate more frequently. It may also cause a smaller and weaker urine stream.
If benign prostatic hyperplasia is not treated, there is a risk of complete blockage of urine flow(acute urinary retention). This requires immediate medical treatment. In some cases, surgery may be necessary to reduce the size of the prostate or remove it. Avidart reduces the production of dihydrotestosterone, which helps to reduce the size of the prostate and alleviate symptoms. This reduces the risk of acute urinary retention and the need for surgery.
Avidart may also be used with another medication called tamsulosin (used to treat symptoms of an enlarged prostate).
??If you think you are in any of these situations,do not takethis medication until you have consulted with your doctor.
This medication is only for men. Women, children, and adolescents should not take it.
Warnings and precautions
Consultyour doctor before starting to take Avidart.
??Consult your doctor or pharmacistif you have any questions about taking Avidart.
Taking Avidart with other medications
Inform your doctor if you are taking, have taken recently, or may need to take any other medication.
Certain medications may interact with Avidart, which may cause adverse effects. Some of these medications are:
??Inform your doctorif you are taking any of these medications. You may need to reduce your Avidart dose.
Taking Avidart with food and drinks
Avidart can be taken with or without food.
Pregnancy, breastfeeding, and fertility
Women whoare pregnant (or may be pregnant) should avoid contact with broken capsules. Dutasteride can be absorbed through the skin and may affect the normal development of the male fetus. This risk is especially important in the first 16 weeks of pregnancy.
Use a condom during sex.Dutasteride has been found in the semen of men taking Avidart. If your partner is pregnant or may be pregnant, you should avoid exposing her to your semen.
Avidart has been shown todecrease sperm count, motility, and semen volume. This may reduce your fertility.
??Consult your doctorif a pregnant woman has come into contact with dutasteride.
Driving and operating machinery
It is unlikely that Avidartwill affect your ability to drive and use machinery.
Avidart contains soy lecithin
This medication contains soy lecithin, so it may contain soy oil. Do not use this medication if you are allergic to peanuts or soy.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. If you do not take Avidart regularly, the control of your PSA levels may be affected. In case of doubt, consult your doctor or pharmacist again.
What dose should you take
If you take more Avidart than you should
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicological Information Service, phone 915620420, indicating the medication and the amount ingested. It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
If you forgot to take Avidart
Do not take a double dose to compensate for the missed doses. Take the next dose at the usual time.
Do not interrupt treatment with Avidart
Do not interrupt treatment with Avidart without consulting your doctor first. You may need up to 6 months or more to notice an effect.
Allergic reaction
The symptoms of an allergic reaction may include:
??Contact your doctorimmediatelyif you experience any of these symptoms andstop taking Avidart.
Common side effects
These may affect up to 1 in 10 patients taking Avidart:
Uncommon side effects
These may affect up to 1 in 100 patients taking Avidart:
Side effects of unknown frequency
The frequency cannot be estimated from the available data:
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not store at a temperature above 86°F (30°C).
Do not use this medication after the expiration date shown on the packaging. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and unused medicines at the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of the packaging and unused medicines. By doing so, you will help protect the environment.
Composition of Avidart
The active ingredient is dutasteride.Each soft capsule contains 0.5 mg of dutasteride.
The other components are:
Appearance of the product and contents of the packaging
Avidart soft capsules are oblong, opaque, yellow, soft gelatin capsules, engraved with GX CE2. They are available in packs of 10, 30, 50, 60, and 90 capsules. Some pack sizes may not be marketed.
Marketing authorization holder and manufacturer responsible
Marketing authorization holder:
GlaxoSmithKline, S.A.
P.T.M. C/ Severo Ochoa, 2
28760 Tres Cantos (Madrid)
Manufacturer responsible:
DelpharmPoznan Spólka Akcyjna
ul. Grunwaldzka 189
60-322 Poznan
Poland
or
Aspen Bad Oldesloe GmbH
Industriestrasse 32-36
23843 Bad Oldesloe
Germany
Local representative:
Casen Recordati, S.L.
Autovía de Logroño, Km 13,300
50180 Utebo (Zaragoza)
Spain
This medicinal product is authorized in the member states of the European Economic Area with the following names:
Avodart- Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, Netherlands, United Kingdom
Avidart- Spain
Date of the last review of this leaflet:November 2017.
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.